Syntegon has launched the AIM9 inspection platform, which combines visual inspection and leak detection with outputs of up to 600 vials per minute. According to the company, the model is designed to help pharmaceutical manufacturers and CMOs achieve the highest inspection and product quality.

“Efficiency is key in the fast-paced pharmaceutical industry,” said Bernd Barkey, president of Syntegon Japan and global head of inspection at Syntegon. “The new AIM9 enables our customers to boost productivity and meet ambitious delivery targets.”

Designed for high-performance environments, the automated vial inspection platform processes up to 600 containers per minute.

The platform accommodates vial sizes from 2 to 250 milliliters and enables easy changeovers as well as fast adaptation for new products. It provides fully integrated container closure integrity testing (CCIT), offering head-space gas analysis, high-voltage leak detection, or both, without the need for additional equipment.

Together with the full range of visual inspection technologies for the detection of particles and cosmetic defects, the new AIM9 ensures maximum detection and minimal false reject rates. Apart from Syntegon’s patented SD technology, area and line-scan cameras, customers can further opt for deep learning integration or the bubble masking tool, which distinguishes harmless bubbles from harmful defects.

“Backed by many decades of experience, we can offer our customers exactly what they need to achieve the required performance, efficiency, and flexibility in their inspection process,” said Bernd Barkey. “AIM9 is available in several variants based on a standardized platform, which allows us to co-create the ideal solution together with our customers.”